Analysts tracking nuclear power startup Oklo (NYSE: OKLO) project the company will consume roughly $6.3 billion in free cash flow between 2026 and 2030, nearly twice its current cash reserves.
With $3.13 billion in cash and securities on hand as of September 30, the arithmetic leaves a multi-billion-dollar hole that will require fresh equity issuance or debt to fill.
That financial reality prompted Craig-Hallum analyst Eric Stine to slash his price target to $27 from $53 on November 9, even though Oklo had just posted better-than-expected third-quarter results.
Oklo’s quarterly loss narrowed to $0.22 per share against the $0.27 Wall Street had forecast, a result that did nothing to reassure Craig-Hallum about the company’s longer-term capital position.
The revised $27 target sits just 4% above the stock’s recent trading price of $26.08, a razor-thin implied upside for a company carrying a $5.1 billion market capitalization.
Stine maintained a Hold rating, mirroring a concern he first raised in March, when Craig-Hallum trimmed its target to $71 from $87 over the same capital adequacy worries.
Oklo’s cash balance technically improved from $3.0 billion at the end of June to $3.13 billion at September 30, but that gain came entirely from continued stock sales totaling $2.3 billion across the first nine months of 2026.
Management reiterated guidance for $400 million to $500 million in plant spending this year and still has not disclosed a construction cost for its first Aurora reactor in Idaho, a figure investors have been waiting on.
The 25 analysts who cover Oklo carry a mean price target of $56, more than double the current share price, yet their own loss estimates have been deteriorating, with the consensus 2027 loss widening to $1.13 per share from $0.96 just 90 days earlier.
Projected 2028 revenue of $39.2 million represents less than a tenth of what Oklo plans to spend on plant construction in 2026 alone, underlining how far commercial operations remain from generating meaningful cash.
At its current market value, investors are effectively paying approximately $2 billion above the company’s net cash for a business that has yet to price its first reactor or sign a binding construction contract.
H.C. Wainwright takes a sharply different view, maintaining a Buy rating and a $90 price target, suggesting that a successful power agreement, such as the potential deal with Meta for its Ohio campus, could dramatically alter the funding calculus.
Until Oklo discloses a cost for the Idaho Aurora plant or secures a binding commercial contract, Craig-Hallum’s conservative stance appears well-grounded, with the company’s annual fiscal report expected in March representing the next meaningful disclosure opportunity.
